Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | OPRD1 | P41143 | 10/20 | 0.42 |
| ▸ | USP2 | O75604 | 3/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.39 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.39 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4153281 | 0.81 | MEN1 (0.53) | MEN1KMT2AOPRD1USP2CYP2C9 | |
| SCHEMBL4153276 | 0.81 | MEN1 (0.53) | MEN1KMT2AOPRD1USP2CYP2C9 | |
| SCHEMBL7317029 | 0.80 | MEN1 (0.51) | MEN1KMT2AOPRD1USP2CYP2C9 | |
| SCHEMBL5623535 | 0.80 | MEN1 (0.51) | MEN1KMT2AOPRD1USP2CYP2C9 | |
| SCHEMBL27994808 | 0.79 | MEN1 (0.50) | MEN1KMT2AOPRD1USP2CYP2C9 | |
| SCHEMBL3919530 | 0.79 | MEN1 (0.50) | MEN1KMT2AOPRD1USP2CYP2C9 | |
| SCHEMBL8051571 | 0.76 | MEN1 (0.47) | MEN1KMT2AOPRD1USP2CYP2C9 | |
| SCHEMBL27402701 | 0.76 | MEN1 (0.51) | MEN1KMT2AOPRD1USP2CYP2C9 | |
| SCHEMBL3643682 | 0.76 | OPRD1 (0.49) | MEN1KMT2AOPRD1USP2CYP2C19 | |
| SCHEMBL5633854 | 0.74 | OPRD1 (0.50) | MEN1KMT2AOPRD1OPRM1SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120064494-A | Method for detecting p-chlorobenzhydryl piperazine in levocetirizine hydrochloride particles | 康芝药业股份有限公司 | 2025-05-30 | — | — | CN | disclosed |
| EP-4321156-A1 | FILM-COATED TABLET WITH IMPROVED STABILITY CONTAINING MONTELUKAST OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND LEVOCETIRIZINE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | Han Wha Pharma Co., Ltd. (KR) | 2024-02-14 | — | — | EP | disclosed |
| CN-117320697-A | Film coated tablet comprising montelukast or a pharmaceutically acceptable salt thereof and levocetirizine or a pharmaceutically acceptable salt thereof with improved stability | 韩和制药株式会社 | 2023-12-29 | — | — | CN | disclosed |
| WO-2023068839-A1 | FILM-COATED TABLET WITH IMPROVED STABILITY CONTAINING MONTELUKAST OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND LEVOCETIRIZINE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | 한화제약주식회사 | 2023-04-27 | — | — | WO | disclosed |
| EP-0546102-A1 | TROPOLONE DERIVATIVES AND PHARMACEUTICAL COMPOSITION THEREOF FOR PREVENTING AND TREATING ISCHEMIC DISEASES. | UPJOHN CO (US) | 1993-06-16 | — | — | EP | disclosed |